DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Niceritrol

Niceritrol

  • Clinical and Laboratory Responses to Niceritrol in the Treatment of Hypercholesterolaemia

    Clinical and Laboratory Responses to Niceritrol in the Treatment of Hypercholesterolaemia

  • Regulation of Pharmaceutical Prices: Evidence from a Reference Price Reform in Denmark

    Regulation of Pharmaceutical Prices: Evidence from a Reference Price Reform in Denmark

  • (12) United States Patent (10) Patent No.: US 6,818,229 B1 Cefali Et Al

    (12) United States Patent (10) Patent No.: US 6,818,229 B1 Cefali Et Al

  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

  • 2 12/ 35 74Al

    2 12/ 35 74Al

  • (12) Patent Application Publication (10) Pub. No.: US 2004/0053975A1 Bova Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2004/0053975A1 Bova Et Al

  • Stembook 2018.Pdf

    Stembook 2018.Pdf

  • Association of Cardiovascular Risk with Inhaled Long-Acting Bronchodilators in Patients with Chronic Obstructive Pulmonary Disease: a Nested Case-Control Study

    Association of Cardiovascular Risk with Inhaled Long-Acting Bronchodilators in Patients with Chronic Obstructive Pulmonary Disease: a Nested Case-Control Study

  • Niacin (Vitamin B3, Nicotinic Acid), Niacinamide Natural Standard Bottom Line Monograph, Copyright © 2011 (

    Niacin (Vitamin B3, Nicotinic Acid), Niacinamide Natural Standard Bottom Line Monograph, Copyright © 2011 (

  • Trends in Lipid-Modifying Agent Use in 83 Countries

    Trends in Lipid-Modifying Agent Use in 83 Countries

  • Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

    Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

  • Marrakesh Agreement Establishing the World Trade Organization

    Marrakesh Agreement Establishing the World Trade Organization

  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs

    Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs

  • Customs Tariff - Schedule

    Customs Tariff - Schedule

  • Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: a Systematic Evidence Review for the U.S

    Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: a Systematic Evidence Review for the U.S

  • ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12

    ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12

  • NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort

    NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort

  • ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019

    ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019

Top View
  • (12) Patent Application Publication (10) Pub. No.: US 2002/0169134A1 Davis (43) Pub
  • (12) United States Patent (10) Patent No.: US 6,365,186 B1 Huval Et Al
  • Treatment Drug Therapy
  • Customs Tariff - Schedule Xxi - 1
  • Combinations of Ileal Bile Acid Transport Inhibitors and Bile Acid Sequestering Agents for Cardiovascular Indications
  • Combinations for Cardiovascular Indications
  • Effects of Lipid-Lowering Drugs on Intermediate-Density Lipoprotein in Uremic Patients
  • Regulation of Pharmaceutical Prices: Evidence from a Reference Price Reform in Denmark∗
  • (12) Patent Application Publication (10) Pub. No.: US 2004/0115258A1 Stroppolo Et Al
  • Harmonized Tariff Schedule of the United States (2006) (Rev
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
  • Regulatory Change in Pharmaceutical Price: Evidence from A
  • Trends in Lipid-Modifying Agent Use in 83 Countries
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
  • WO 2008/030382 Al
  • (12) United States Patent (10) Patent No.: US 6,638,969 B1 Keller Et Al
  • Resolution Ap (2000) 1
  • Pharmaceutical Appendix to the Tariff Schedule 2


© 2024 Docslib.org    Feedback